True or False: DDVAP is used for children under the age of 6 for enuresis treatment.

The statement regarding DDAVP (desmopressin) being used for children under the age of 6 for enuresis treatment is false. Although DDAVP is an effective treatment for nocturnal enuresis (bedwetting) and can be used in children, it is generally recommended for those older than 6 years. The reason for this age guideline includes safety and the development of the bladder control mechanisms, which are typically more mature in children beyond this age.

Additionally, while DDAVP is a first-line treatment option for enuresis in older children, it is not suitable for use in infants or children under 6 due to the potential for water retention and electrolyte imbalances that can occur with its use. This makes the recommendation against its use in very young children important from a safety perspective.